Literature DB >> 31865424

Dissociation of nicotinic α7 and α4/β2 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates.

Marzyeh Azimi1, Mariann Oemisch1,2, Thilo Womelsdorf3,4.   

Abstract

RATIONALE: Nicotinic acetylcholine receptors (nAChRs) modulate attention, memory, and higher executive functioning, but it is unclear how nACh sub-receptors mediate different mechanisms supporting these functions.
OBJECTIVES: We investigated whether selective agonists for the alpha-7 nAChR versus the alpha-4/beta-2 nAChR have unique functional contributions for value learning and attentional filtering of distractors in the nonhuman primate.
METHODS: Two adult rhesus macaque monkeys performed reversal learning following systemic administration of either the alpha-7 nAChR agonist PHA-543613 or the alpha-4/beta-2 nAChR agonist ABT-089 or a vehicle control. Behavioral analysis quantified performance accuracy, speed of processing, reversal learning speed, the control of distractor interference, perseveration tendencies, and motivation.
RESULTS: We found that the alpha-7 nAChR agonist PHA-543613 enhanced the learning speed of feature values but did not modulate how salient distracting information was filtered from ongoing choice processes. In contrast, the selective alpha-4/beta-2 nAChR agonist ABT-089 did not affect learning speed but reduced distractibility. This dissociation was dose-dependent and evident in the absence of systematic changes in overall performance, reward intake, motivation to perform the task, perseveration tendencies, or reaction times.
CONCLUSIONS: These results suggest nicotinic sub-receptor specific mechanisms consistent with (1) alpha-4/beta-2 nAChR specific amplification of cholinergic transients in prefrontal cortex linked to enhanced cue detection in light of interferences, and (2) alpha-7 nAChR specific activation prolonging cholinergic transients, which could facilitate subjects to follow-through with newly established attentional strategies when outcome contingencies change. These insights will be critical for developing function-specific drugs alleviating attention and learning deficits in neuro-psychiatric diseases.

Entities:  

Keywords:  Acetylcholine; Attention; Nicotine; Nonhuman primate; Reversal learning

Mesh:

Substances:

Year:  2019        PMID: 31865424     DOI: 10.1007/s00213-019-05430-w

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

Authors:  Cecilia Gotti; Michele Zoli; Francesco Clementi
Journal:  Trends Pharmacol Sci       Date:  2006-07-31       Impact factor: 14.819

2.  A neural circuit model of flexible sensorimotor mapping: learning and forgetting on multiple timescales.

Authors:  Stefano Fusi; Wael F Asaad; Earl K Miller; Xiao-Jing Wang
Journal:  Neuron       Date:  2007-04-19       Impact factor: 17.173

3.  ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.

Authors:  M W Decker; A W Bannon; P Curzon; K L Gunther; J D Brioni; M W Holladay; N H Lin; Y Li; J F Daanen; J J Buccafusco; M A Prendergast; W J Jackson; S P Arneric
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

4.  Automatic implantable defibrillators--lost opportunities.

Authors:  F Weale
Journal:  Br J Hosp Med       Date:  1989-03

5.  [Recent technics in ophthalmology and their significance for the physician in general practice].

Authors:  A Bronner
Journal:  Dtsch Med J       Date:  1972-03-10

6.  Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity.

Authors:  Zhenglin Gu; Jerrel L Yakel
Journal:  Neuron       Date:  2011-07-14       Impact factor: 17.173

7.  [Angiographic and morphologic criteria of the manifestation of arteriolonephrosclerosis in vasorenal hypertension].

Authors:  S A Turpitko; S V Iargin; P F Petrovskiĭ; A A Klembovskiĭ; V B Gerasimov
Journal:  Urol Nefrol (Mosk)       Date:  1989 Mar-Apr

8.  Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability.

Authors:  S Guzzetti; E Piccaluga; R Casati; S Cerutti; F Lombardi; M Pagani; A Malliani
Journal:  J Hypertens       Date:  1988-09       Impact factor: 4.844

9.  Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms.

Authors:  Jane A Dickinson; James N C Kew; Susan Wonnacott
Journal:  Mol Pharmacol       Date:  2008-04-29       Impact factor: 4.436

10.  Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.

Authors:  Robert W Gould; Pradeep K Garg; Sudha Garg; Michael A Nader
Journal:  Neuropharmacology       Date:  2012-08-23       Impact factor: 5.250

View more
  3 in total

1.  Nicotine promotes the utility of short-term memory during visual search in macaque monkeys.

Authors:  Ryo Sawagashira; Masaki Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2022-07-08       Impact factor: 4.415

Review 2.  Novel Pharmacotherapies in Parkinson's Disease.

Authors:  Yousef Tizabi; Bruk Getachew; Michael Aschner
Journal:  Neurotox Res       Date:  2021-05-18       Impact factor: 3.911

Review 3.  Nicotine and the nicotinic cholinergic system in COVID-19.

Authors:  Yousef Tizabi; Bruk Getachew; Robert L Copeland; Michael Aschner
Journal:  FEBS J       Date:  2020-08-25       Impact factor: 5.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.